We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PEN market cap is 10.68B. The company's latest EPS is USD 0.3638 and P/E is 762.37.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 284.68M | 278.66M | 299.4M | 301.04M | 315.52M |
| Operating Income | 35.03M | 12.1M | -80.96M | 35.36M | 42.78M |
| Net Income | 54.22M | 11M | -60.2M | 29.53M | 33.68M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 560.41M | 747.59M | 847.13M | 1.06B | 1.19B |
| Operating Income | -38.94M | -7.5M | 6.08M | 73.55M | 9.28M |
| Net Income | -15.7M | 5.28M | -2M | 90.95M | 14.01M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.56B | 1.58B | 1.53B | 1.48B | 1.53B |
| Total Liabilities | 377.36M | 376.31M | 373.33M | 374.84M | 382.25M |
| Total Equity | 1.18B | 1.2B | 1.16B | 1.1B | 1.15B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 822.98M | 1.24B | 1.37B | 1.56B | 1.53B |
| Total Liabilities | 185.2M | 290.32M | 372.03M | 377.36M | 382.25M |
| Total Equity | 637.79M | 953.93M | 998.86M | 1.18B | 1.15B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 97.33M | 38.3M | 60.91M | 117.37M | 168.48M |
| Investing | -16.08M | 18.38M | 52.86M | 88.58M | 77.62M |
| Financing | 16.2M | -794k | 7.48M | -93.07M | -87.01M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.24M | 9.5M | -55.66M | 97.33M | 168.48M |
| Investing | -104.15M | -21.74M | 54.79M | -16.08M | 77.62M |
| Financing | 134.92M | 836k | 11.62M | 16.2M | -87.01M |
| Market Cap | 10.68B |
| Price to Earnings Ratio | 762.37 |
| Price to Sales Ratio | 8.94 |
| Price to Cash Ratio | 32.93 |
| Price to Book Ratio | 9.28 |
| Dividend Yield | - |
| Shares Outstanding | 38.52M |
| Average Volume (1 week) | 412.3k |
| Average Volume (1 Month) | 429.22k |
| 52 Week Change | 32.40% |
| 52 Week High | 310.00 |
| 52 Week Low | 148.00 |
| Spread (Intraday) | 13.22 (4.6%) |
| Company Name | Penumbra Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.penumbrainc.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
